Daclizumab: Clinical trial of monoclonal antibody for the treatment of MS
Kreutzkamp, B.
Medizinische Monatsschrift für Pharmazeuten 37(6) 202-206; Quiz: 207-208
2014
ISSN/ISBN: 0342-9601 PMID: 25051810 Document Number: 675232
Document emailed within 1 workday
Related Documents
Hengster, P.; Pescovitz, M.D.; Hyatt, D.; Margreiter, R. 1999: Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection. Roche Study Group Transplantation 68(2): 310-313Huang, X-dong.; Yi, J-lin.; Gao, L.; Xu, G-zhen.; Jin, J.; Yang, W-zhi.; Lu, T-xiang.; Wu, S-xiong.; Wu, R-rui.; Hu, W-han.; Xie, W-chang.; Han, F.; Gao, Y-hong.; Gao, J-ming.; Pan, J-ji.; Chen, C-ben.; Lang, J-yi.; Li, T.; Dong, Y.; Fu, Y-bing.; Fan, L.; Li, B-sen.; Li, J.; Wang, X-huai.; Chen, B-xu.; Gao, X-shu.; Zhang, P.; Wu, X-wei.; Hu, B-qiang. 2007: Multi-center phase II clinical trial of humanized anti-epidermal factor receptor monoclonal antibody h-R3 combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma Zhonghua Zhong Liu Za Zhi 29(3): 197-201
Ter Meulen, C.G.; Hilbrands, L.B.; van Riemsdijk-van Overbeeke, I.C.; Hené, R.J.; Christiaans, M.H.; Hoitsma, A.J. 2000: Daclizumab and basiliximab: monoclonal mouse-man antibodies with effective immunosuppression without side effects Nederlands Tijdschrift Voor Geneeskunde 144(50): 2396-2400
Kovarik, J.; Zlabinger, G.J.; Wolfram, J.; Pecherstorfer, M.; Watschinger, B.; Traindl, O.; Pohanka, E.; Sonnleitner, A.; Ulrich, W. 1989: OKT3 monoclonal antibody treatment in renal transplant recipients--clinical experience in 49 patients Transplantation Proceedings 21(1 Part 2): 1748-1752
van der Heijden, R.W.; Bunschoten, H.; Pascual, V.; Uytdehaag, F.G.; Osterhaus, D.M.; Capra, J.D. 1990: Nucleotide sequence of a human monoclonal anti-idiotypic antibody specific for a rabies virus-neutralizing monoclonal idiotypic antibody reveals extensive somatic variability suggestive of an antigen-driven immune response Journal of Immunology 144(7): 2835-2839
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Blottière, H.M.; Douillard, J.Y.; Koprowski, H.; Steplewski, Z. 1990: Immunoglobulin class and immunoglobulin G subclass analysis of human anti-mouse antibody response during monoclonal antibody treatment of cancer patients Cancer Research 50(3 Suppl): 1051s-1054s
Berger, W.E. 2000: Clinical trials results of a unique monoclonal antibody in asthma Allergie et Immunologie 32(9): 333-335
Campos Villarino, L.M.; Pajares Vinardell, M.; Freire Macias, J.M.; Vale Gonsalves, E.I.; Millán Núñez-Cortés, J.; Senra Varela, A. 1991: Diagnosis using monoclonal antibody imaging in the clinical follow-up of colorectal cancer Anales de Medicina Interna 8(8): 377-381
Etoh, T. 1985: Analysis of tumor antigens and clinical applications of monoclonal antibody (A 2 B 5) for neuroblastoma Gan no Rinsho. Japan Journal of Cancer Clinics 31(3): 299-302
Davis, T.; Gore-Langton, R.E.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab Oncology 14(10): 1437; 1440-1443
Heinzl, S. 2000: Trastuzumab. Monoclonal antibody for the treatment of breast cancer Medizinische Monatsschrift für Pharmazeuten 23(11): 350-352
Asakura, H. 2002: Treatment of ulcerative colitis and Crohn's disease with monoclonal antibody Nihon Rinsho. Japanese Journal of Clinical Medicine 60(3): 531-538
Vento, S.; Salpietro, V.; Giordano, L.; Ugliola, M.; Costa, G.M.; Cavaciocchi, P.; Russomanno, E. 1983: Benign monoclonal gammopathies: probable antibody specificity of monoclonal immunoglobulins Minerva Medica 74(41): 2439-2445
Scopsi, L.; Bock, E.; Larsson, L.I. 1986: Monoclonal antibody immunocytochemistry: novel method extending usefulness of monoclonal antibodies for antigen visualization European Journal of Cell Biology 41(1): 97-101
Douillard, J.Y.; Laborda, J.; Burg, C.; Ridge, J.; Levenbook, I.; Blottière, H.; Sela, B.; Hoffman, T.; Ben Ami, S. 1989: Monoclonal antibodies to a rat colon carcinoma: model for monoclonal antibody therapy of solid tumors Cancer Research 49(3): 687-692
Sawada, T.; Hashimoto, S. 2007: Human monoclonal antibody to B-lymphocyte stimulator (belimumab) and humanized anti-LFA-1 monoclonal antibodies (efalizumab) Nihon Rinsho. Japanese Journal of Clinical Medicine 65(7): 1239-1242
van Emmerik, N.E.; Knoop, C.J.; Vaessen, L.M.; Balk, A.H.; Mochtar, B.; Claas, F.H.; Weimar, W. 1998: C1.7 monoclonal antibody designates high-avidity CD4+ cytotoxic T lymphocytes involved in clinical heart rejection Transplantation 66(1): 135-138
Wilkes, G.M. 2011: Ipilimumab, a human monoclonal antibody for treatment of unresectable or metastatic melanoma Oncology 25(7 Suppl Nurse Ed): 46-47
Edelman, L.; Colignon, A.; Shermann, J.M.; Girre, C.; Dally, S.; Reviron, J. 1984: Preparation and experimentation of an antidigitalin monoclonal antibody: interest in human treatment Developments in Biological Standardization 57: 343-347